EVALUATING DRUG SAFETY IN THE ERA OF COVID-19: A REVIEW OF PHARMACOVIGILANCE PRACTICES

EVALUATING DRUG SAFETY IN THE ERA OF COVID-19: A REVIEW OF PHARMACOVIGILANCE PRACTICES
Author(s):
Geethika Pravanya Alla, Pallagolla Harika, Harshitha Nagothu
Keywords:
COVID-19, pharmacovigilance, drug safety assessment.
Abstract
The COVID-19 pandemic has led to the rapid development and widespread use of various medications to treat and prevent the virus. As with any new drug, it is important to carefully assess the safety and effectiveness of the treatments. This review aims to examine pharmacovigilance practices for evaluating drug safety in the context of COVID-19. We begin by defining pharmacovigilance, its functions and importance during the pandemic era. This report also discusses about various types of data sources used in pharmacovigilance, including spontaneous reporting systems, clinical trials, and observational studies. Finally, conclude with the challenges and limitations of pharmacovigilance during the COVID-19 pandemic and suggested strategies for improving drug safety monitoring in this rapidly evolving situation. Overall, this article highlights the crucial role of pharmacovigilance in ensuring safe and effective use of medications in the fight against COVID-19.
Article Details
Unique Paper ID: 157684 Publication Volume & Issue: Volume 9, Issue 7 Page(s): 752 - 759
Article Preview & Download

Share This Article

NCSEM 2024

National Conference on Sustainable Engineering and Management - 2024

Last Date: 15th March 2024

IJIRT.org enables door in research by providing high quality research articles in open access market.

Send us any query related to your research on editor@ijirt.org